EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight

Golnaz Mahmoudvand, Arian Karimi Rouzbahani, Zahra Sadat Razavi, Mohamad Mahjoor, Hamed Afkhami

Frontiers in Bioengineering and Biotechnology · 13.04.2023 · 11

DOI: 10.3389/fbioe.2023.1158484 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 13.04.2023. Verfasst von Golnaz Mahmoudvand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcer (DFU) is considered the most catastrophic complication of diabetes mellitus (DM), leading to repeated hospitalizations, infection, gangrene, and finally amputation of the limb. In patients suffering from diabetes mellitus, the wound-healing process is impaired due to various factors such as endothelial dysfunction and synthesis of advanced glycation end-products, hence, conventional therapeutic interventions might not be effective. With increasing therapeutic applications of mesenchymal stem cells (MSCs) in recent years, their potential as a method for improving the wound-healing process has gained remarkable attention. In this field, mesenchymal stem cells exert their beneficial effects through immunomodulation, differentiation into the essential cells at the site of ulcers, and promoting angiogenesis, among others. In this article, we review cellular and molecular pathways through which mesenchymal stem cell therapy reinforces the healing process in non-healing Diabetic foot ulcers.

Schlagwörter

Stichwörter der Autor:innen

diabetic footfoot ulcermesenchymal stem cellmultipotent stem cellwound healing

Autor:innen und Institutionen

  • Student Research Committee, USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran.
  • Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Medical Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.

Zitieren

APA

Mahmoudvand, G., Karimi Rouzbahani, A., Razavi, Z. S., Mahjoor, M., & Afkhami, H. (2023). Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1158484

Vancouver

Mahmoudvand G, Karimi Rouzbahani A, Razavi ZS, Mahjoor M, Afkhami H. Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1158484

BibTeX
@article{Mahmoudvand2023,
  author = {Mahmoudvand, Golnaz and Karimi Rouzbahani, Arian and Razavi, Zahra Sadat and Mahjoor, Mohamad and Afkhami, Hamed},
  title = {Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fbioe.2023.1158484}
}
Kostenlos starten →